Highlights
- •Patients with Parkinson’s disease have an increased risk of perioperative morbidity.
- •Awareness of anaesthetic risks and medication requirements may improve outcomes.
- •There is little evidence linking anaesthetic exposure to development of the disease.
Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Clinical NeuroscienceReferences
- The pathogenesis of Parkinson's disease: a new hypothesis.Can Med Assoc J. 1962; 87: 802-807
- Structural changes of the substantia nigra in Parkinson’s disease as revealed by MR imaging.Am J Neuroradiol. 2000; 21: 697-701
- Parkinson's disease and anaesthesia.Br J Anaesth. 2002; 89: 904-916
- The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.Mov Disord. 2011; 26: 399-406
- Epidemiology of Parkinson’s disease.LancetNeurol. 2006; 5: 525-535
Deloitte Access Economics. Living with Parkinson's Disease: An updated economic analysis 2014 http://www.parkinsons.org.au/Documents/Living%20with%20Parkinsons%2027082015%20FINAL.pdf; 2015.
- Why we need better nationwide measures of Parkinson’s disease incidence and prevalence in Australia.Aust Epidemiol. 2013; 20: 20-22
- Alzheimer's disease and Parkinson's disease.N Engl J Med. 2003; 348: 1356-1364
- Parkinson's disease influences the perioperative risk profile in surgery.Langenbecks Arch Surg. 2009; 394: 511-515
- Hip fractures in patients with Parkinson's syndrome.J Trauma. 1983; 23: 98-101
- Postoperative complications in Parkinson's disease.J Am Geriatr Soc. 1999; 47: 967-972
- Anaesthesia in patients with Parkinson’s disease.Anaesthesist. 2005; 54 (quiz 410-401): 401-409
- Parkinson’s disease and anaesthesia.Indian J Anaesth. 2011; 55: 228-234
- Clinical problems in the hospitalized Parkinson's disease patient: systematic review.Mov Disord. 2011; 26: 197-208
- Postoperative rigidity following fentanyl anesthesia.Anesthesiology. 1983; 58: 275-277
- Propofol-induced dyskinesias in Parkinson's disease.Anesth Analg. 1996; 83: 420-422
- Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson disease.Clin Neuropharmacol. 2009; 32: 48-50
- Severe adverse interaction between pethidine and selegiline.Lancet. 1991; 337: 246
- Medication management in people with Parkinson's disease during surgical admissions.Postgrad Med J. 2010; 86: 334-337
- Surgical intervention and anesthetic management of the patient with Parkinson's disease.Int Anesthesiol Clin. 1996; 34: 133-150
Australian Bureau of Statistics. Australian Demographic Statistics 3101.0. ABS, Canberra http://www.ausstats.abs.gov.au/Ausstats/subscriber.nsf/0/801757AC98D5DE8FCA257F1D00142620/$File/31010_jun%202015.pdf; 2015.
- Deterioration of Parkinson's disease during hospitalization: survey of 684 patients.BMC Neurol. 2012; 12: 13
- Obstructive respiratory dysfunction in parkinsonian patients.Am Rev Respir Dis. 1967; 95: 33-47
- Impaired efficacy of cough in patients with Parkinson disease.Chest. 2003; 124: 1009-1015
- Parkinsonism: onset, progression and mortality.Neurology. 1967; 17: 427-442
- Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial.Neurology. 2010; 75: 1912-1919
- Postextubation laryngeal spasm in an unanesthetized patient with Parkinson's disease.J Clin Anesth. 1991; 3: 314-316
- Laryngospasm in neurological diseases.Neurocrit Care. 2006; 4: 163-167
- Persistent perioperative laryngospasm in a patient with Parkinson’s disease.Can J Anaesth. 1998; 45 (495 495)
- Pulmonary function in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1989; 52: 329-333
- Respiratory muscle dysfunction in Parkinson’s disease.Am Rev Respir Dis. 1988; 138: 266-271
- Prevalence of oropharyngeal dysphagia in Parkinson's disease: a meta-analysis.Parkinsonism Related Disord. 2012; 18: 311-315
- Swallowing impairment and pulmonary dysfunction in Parkinson's disease: the silent threats.J Neurol Sci. 2014; 339: 149-152
- Dysphagia in Parkinson's disease is responsive to levodopa.Parkinsonism Related Disord. 2013; 19: 282-284
- The effect of levodopa on pulmonary function in Parkinson's disease: a systematic review and meta-analysis.Clin Ther. 2012; 34: 1049-1055
- Treatment effects for dysphagia in Parkinson's disease: a systematic review.Parkinsonism Related Disord. 2014; 20: 800-807
- Effects of therapy for dysphagia in Parkinson's disease: systematic review.Dysphagia. 2009; 24: 91-102
- Does a specialist unit improve outcomes for hospitalized patients with Parkinson's disease?.Parkinsonism Related Disord. 2014; 20: 1242-1247
- Cardiovascular autonomic dysfunction in Parkinson's disease.J Neurol Sci. 2010; 289: 74-80
- Surgical complications in patients with Parkinson's disease after posteroventral pallidotomy.Neurosurgery. 2003; 52 (discussion 568-571): 558-571
- The dopamine agonist bromocriptine induces hypotension by venous and arteriolar dilation.J Cardiovasc Pharmacol. 1984; 6: 582-587
- Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review.Arch Gen Psychiatry. 1981; 38: 815-820
- Antipsychotic drugs and QT prolongation.Int Clin Psychopharmacol. 2005; 20: 243-251
- Prescription of drugs with potential adverse effects on cardiac conduction in Parkinson's disease.Parkinsonism Related Disord. 2013; 19: 586-589
- QT interval prolongation predicts cardiovascular mortality in an apparently healthy population.Circulation. 1991; 84: 1516-1523
- Prolongation of QTc and risk of stroke: The REGARDS (REasons for Geographic and Racial Differences in Stroke) study.J Am Coll Cardiol. 2012; 59: 1460-1467
- Valvular heart disease and the use of dopamine agonists for Parkinson's disease.N Engl J Med. 2007; 356: 39-46
- Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review.J Neurosurg. 2012; 116: 84-94
- Patient and carer perception of the management of Parkinson's disease after surgery.Age Ageing. 2001; 30: 171-172
- Inappropriate antidopaminergic drug use in Parkinson’s disease inpatients.Curr Drug Ther. 2012; 7: 164-169
- Managing Parkinson’s disease during surgery.BMJ (Clin Res Ed). 2010; 341: c5718
- Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens.BMJ (Clin Res Ed). 1987; 295 (250)
- Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.Pharmacoepidemiol Drug Saf. 2010; 19: 881-888
- Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.Drug Saf. 2010; 33: 1003-1014
- Acute dystonia after alfentanil in untreated Parkinson's disease.Anesth Analg. 1991; 72: 557-558
- Anaesthesia in elderly patients with neurodegenerative disorders: special considerations.Drugs Aging. 2004; 21: 229-242
- μ- and δ-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson’s disease.Exp Neurol. 2001; 171: 139-146
- Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.Neuropharmacology. 2003; 45: 954-963
- Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica.J Neural Transm (Vienna, Austria: 1996). 1999; 106: 725-728
- Effect of postoperative analgesia on major postoperative complications: a systematic update of the evidence.Anesth Analg. 2007; 104: 689-702
- Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?.Ann Neurol. 1998; 44: S115-S120
- A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.Arch Neurol. 2005; 62: 241-248
- The pharmacology of selegiline ((−)deprenyl). New aspects.Acta Neurol Scand Supplementum. 1989; 126: 83-91
- Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy.Ther Clin Risk Manag. 2007; 3: 467-474
- Deprenyl in Parkinson’s disease.Lancet. 1977; 310: 791-795
- Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group.Neurology. 1997; 48: 1070-1077
- Drug interactions with selegiline versus rasagiline.Basal Ganglia. 2012; 2: S27-S31
- A review of the pharmacology of selegiline.Acta Neurol Scand Supplementum. 1991; 136: 44-59
- Serotonin syndrome.Ochsner J. 2013; 13: 533-540
- Rasagiline-induced serotonin syndrome.Mov Disord. 2011; 26: 766-767
- The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice.Br J Pharmacol. 1969; 36: 470-480
- Depression in Parkinson disease–epidemiology, mechanisms and management.Nat Rev Neurol. 2012; 8: 35-47
- Intraoperative exacerbation of Parkinson's disease.Anesth Analg. 1992; 75: 850-853
- Nasogastric medication for perioperative Parkinson's rigidity during anaesthesia emergence.Anaesth Intensive Care. 2011; 39: 1128-1130
Australian and New Zealand College of Anaesthetists. Recommendations for the perioperative care of patients selected for day care surgery PS15, http://www.anzca.edu.au/resources/professional-documents/pdfs/ps15-2010-recommendations-for-the-perioperative-care-of-patients-selected-for-day-care-surgery.pdf; 2010.
- Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease.Eur J Clin Pharmacol. 1991; 41: 463-466
- Gastroesophageal reflux with nasogastric tubes. Effect of nasogastric tube size.Am J Resp Crit Care Med. 1994; 149: 1659-1662
- Literature review: intermittent subcutaneous apomorphine therapy in Parkinson's disease.Neurology. 2004; 62: S12-S17
- Perioperative problems in Parkinson's disease and their management: apomorphine with rectal domperidone.Can J Neurol Sci Le journal canadien des sciences neurologiques. 1996; 23: 198-203
- Subcutaneous apomorphine: an evidence-based review of its use in Parkinson's disease.Drugs Aging. 2004; 21: 687-709
- Transdermal rotigotine for the perioperative management of Parkinson’s disease.J Neural Transm. 2010; 117: 855-859
- Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study.J Neurol Neurosurg Psychiatry. 2002; 72: 721-725
- Swallowing abnormalities and their response to treatment in Parkinson's disease.Neurology. 1989; 39: 1309-1314
- Prescribing medications in Parkinson's disease (PD) patients during acute admissions to a District General Hospital.Parkinsonism Related Disord. 2007; 13: 539-540
- Management of the hospitalized patient with Parkinson’s disease: Current state of the field and need for guidelines.Parkinsonism Related Disord. 2011; 17: 139-145
- Parkinson's disease and hospitalization: the need for guidelines.Parkinsonism Related Disord. 2011; 17: 498
- Care of patients with Parkinson's disease in the operating department.J Perioperative Pract. 2010; 20: 406-410
- Anticholinergic treatment for choreoathetosis in a child after induction with propofol.Anesth Analg. 1996; 82: 670
- Different actions of general anesthetics on the firing patterns of neocortical neurons mediated by the GABA(A) receptor.Anesthesiology. 1999; 91: 500-511
- Levodopa response motor complications–GABA receptors and preproenkephalin expression in human brain.Parkinsonism Related Disord. 2002; 8: 449-454
- Propofol-induced dyskinesias controlled with dexmedetomidine during deep brain stimulation surgery.Anesthesiology. 2006; 104: 1337-1339
- Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.Anesth Analg. 2010; 111: 1285-1289
- The functional anatomy of basal ganglia disorders.Trends Neurosci. 1989; 12: 366-375
- Ballism not related to vascular disease: A report of 16 patients and review of the literature.Parkinsonism Related Disord. 1996; 2: 35-45
- Anaesthesia and Parkinson's disease: how to manage with new therapies?.Curr Opin Anaesthesiol. 2009; 22: 419-424
- Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anaesthesia.Synapse (New York, NY). 1991; 7: 169-171
- Inhibition of dopamine transport in rat brain synaptosomes by volatile anesthetics.Anesthesiology. 1993; 78: 750-756
- Hyperlocomotion during recovery from isoflurane anesthesia is associated with increased dopamine turnover in the nucleus accumbens and striatum in mice.Anesthesiology. 1997; 86: 464-475
- Cardiovascular effects of levodopa.JAMA. 1971; 218: 1921-1923
- Prevention or reversal of levodopa-induced cardiac arrhythmias by decarboxylase inhibitors.Lancet. 1970; 2: 1014-1015
- Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.J Neurosci. 2003; 23: 876-882
- Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys.Neurotoxicol Teratol. 2011; 33: 220-230
- Potential mechanism of cell death in the developing rat brain induced by propofol anesthesia.Int J Dev Neurosci. 2009; 27: 279-287
- Anaesthesia and the developing brain.South Afr J Anaesth Analgesia. 2014; 20: 167-169
- Early childhood general anaesthesia exposure and neurocognitive development.Br J Anaesth. 2010; 105: i61-i68
- Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways.Neuroscience. 2005; 135: 815-827
- The glutaminergic, GABAergic, dopaminergic but not cholinergic neurons are susceptible to anaesthesia-induced cell death in the rat developing brain.Neuroscience. 2011; 174: 64-70
- Neurodevelopment of children exposed to anesthesia: design of the Mayo Anesthesia Safety in Kids (MASK) study.Contemporary Clin Trials. 2015; 41: 45-54
- Long-term differences in language and cognitive function after childhood exposure to anesthesia.Pediatrics. 2012; 130: e476-e485
- Early exposure to anesthesia and learning disabilities in a population-based birth cohort.Anesthesiology. 2009; 110: 796-804
- Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar.Br J Anaesth. 2013; 111: 143-151
- Newly postulated neurodevelopmental risks of pediatric anesthesia: theories that could rock our world.J Urol. 2013; 189: 1222-1228
- Exposure to anesthetic gases and Parkinson’s disease: a case report.BMC Neurol. 2013; 13 (194)
- Parkinson's disease mortality among male anesthesiologists and internists.Mov Disord. 2005; 20: 1614-1617
- Familial and environmental risk factors in Parkinson's disease: a case-control study in north-east Italy.Acta Neurol Scand. 2002; 105: 77-82
- From motivation to action: functional interface between the limbic system and the motor system.Prog Neurobiol. 1980; 14: 69-97
- Isoflurane anesthesia induced persistent, progressive memory impairment, caused a loss of neural stem cells, and reduced neurogenesis in young, but not adult, rodents.J Cerebral Blood Flow Metabol. 2010; 30: 1017-1030
- Evidence for neurogenesis in the adult mammalian substantia nigra.Proc Natl Acad Sci USA. 2003; 100: 7925-7930
- Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice.Stem Cells (Dayton, Ohio). 2006; 24: 1280-1287
- Epidemiology and etiology of Parkinson's disease: a review of the evidence.Eur J Epidemiol. 2011; 26: S1-S58
- Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism.Lancet Neurol. 2006; 5: 355-363